[HTML][HTML] The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions
Epilepsy has a profound impact on quality of life. Despite the development of new
antiseizure medications (ASMs), approximately one-third of affected patients have drug …
antiseizure medications (ASMs), approximately one-third of affected patients have drug …
[HTML][HTML] The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions
S Tripathi, CL Nathan, MC Tate, CM Horbinski… - JCI …, 2024 - Am Soc Clin Investig
Epilepsy has a profound impact on quality of life. Despite the development of new
antiseizure medications (ASMs), approximately one-third of affected patients have drug …
antiseizure medications (ASMs), approximately one-third of affected patients have drug …
The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions
S Tripathi, CL Nathan, MC Tate, CM Horbinski… - JCI …, 2024 - scholars.northwestern.edu
Epilepsy has a profound impact on quality of life. Despite the development of new
antiseizure medications (ASMs), approximately one-third of affected patients have drug …
antiseizure medications (ASMs), approximately one-third of affected patients have drug …
The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions.
S Tripathi, CL Nathan, MC Tate, CM Horbinski… - JCI Insight, 2024 - europepmc.org
Epilepsy has a profound impact on quality of life. Despite the development of new
antiseizure medications (ASMs), approximately one-third of affected patients have drug …
antiseizure medications (ASMs), approximately one-third of affected patients have drug …
The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions
S Tripathi, CL Nathan, MC Tate, CM Horbinski… - JCI …, 2024 - pubmed.ncbi.nlm.nih.gov
Epilepsy has a profound impact on quality of life. Despite the development of new
antiseizure medications (ASMs), approximately one-third of affected patients have drug …
antiseizure medications (ASMs), approximately one-third of affected patients have drug …
[HTML][HTML] The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions
S Tripathi, CL Nathan, MC Tate, CM Horbinski… - JCI …, 2024 - Am Soc Clin Investig
Epilepsy affects approximately 1% of the population and can lead to a substantial decrease
in quality of life and death in up to 5% of patients (1). Current treatment options focus on …
in quality of life and death in up to 5% of patients (1). Current treatment options focus on …
The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions.
S Tripathi, CL Nathan, MC Tate, CM Horbinski… - JCI Insight, 2024 - europepmc.org
Epilepsy has a profound impact on quality of life. Despite the development of new
antiseizure medications (ASMs), approximately one-third of affected patients have drug …
antiseizure medications (ASMs), approximately one-third of affected patients have drug …